StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Chandan Taparia, Motilal Oswal

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))30 Mar 2026via ET Now

Entry₹2,120Stated
Target₹2,230
Total upside +5.19% (call closed)
Stop lossNot given
Exit₹2,2301 Apr 2026, 9:25 am
Target hit+5.19%0.00%upside left
Follow Chandan Taparia for new calls(31% target hit, 250 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 2 active Swing calls on GLENMARKSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:03 pm IST
1 supporting0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·30 Mar · yesterday

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Chandan Taparia, Motilal Oswal

Every call and its outcome